Dr. Fade A. Mahmoud, MD
- Medicare services, 2024
- 709
- Medicare patients, 2024
- 262
- Part D claims, 2024
- 875
- Publications
- 50
- Clinical trials
- 5
- Practice address
- 1900 North Higley Road, Gilbert, AZ 85234
- Practice phone
- Call (480) 543-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Mahmoud's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Fade A. Mahmoud is a medical oncologist in Gilbert, Arizona
Dr. Mahmoud practices at Banner Gateway Medical Center in Gilbert, Arizona, part of Banner Health.
Dr. Mahmoud's NPI, 1568420966, was assigned on May 3, 2006. Dr. Mahmoud graduated from University of Tichreen Faculty of Medicine in 1996. Dr. Mahmoud holds Arizona license 54812.
- NPI
- 1568420966NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6800890294
- NPI enumeration date
- May 3, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (480) 543-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 56
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Fade A. Mahmoud practices at Banner Gateway Medical Center in Gilbert, Arizona
Dr. Mahmoud's primary practice is Banner Gateway Medical Center, at 1900 North Higley Road, Gilbert, AZ 85234 in Maricopa County. The practice phone is (480) 543-2000.
- Banner Gateway Medical Center1900 North Higley Road, Gilbert, AZ 85234 · Maricopa CountyPhone(480) 543-2000
Source: Dmand AI Affiliation Data
Dr. Fade A. Mahmoud is affiliated with 4 sites of care and 1 medical group
Dr. Mahmoud's primary practice is Banner Gateway Medical Center in Gilbert, Arizona, part of Banner Health. Dr. Mahmoud is also affiliated with Banner Thunderbird Medical Center. The medical group on file is Banner Cancer Center Specialists LLC. Dmand AI also links Dr. Mahmoud to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Fade A. Mahmoud's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahmoud practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Banner Gateway Medical Center | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Banner Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Fade A. Mahmoud is one of 60 medical oncologists in Arizona
Medical oncology is Dr. Mahmoud's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mahmoud is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Mahmoud's licenses on file in 5 states: Arizona, California, Colorado, Arkansas and Massachusetts.
Specialties and state licenses
- Medical oncology, ArizonaPrimary
- California license
- Colorado license
- Arkansas license
- Internal medicine, Massachusetts
Clinical focus
Dmand AI lists breast cancer, chronic leukemia, lung cancer and prostate cancer among the conditions Dr. Mahmoud treats.
Medical oncologists near Dr. Mahmoud
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Fade A. Mahmoud billed Medicare for 709 services in 2024
CMS data shows 709 Medicare services from Dr. Mahmoud across 5 procedure codes in 2024, all of them office visits, for 262 Medicare patients. Medicare paid $54,125 for them.
Dr. Mahmoud's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8292024: 70914%
Where Dr. Mahmoud's Medicare services took place, 2024
- In an office203%
- In a facility68997%
Dr. Mahmoud compared with the Arizona median for medical oncologists, 2024
- Dr. Mahmoud
- Arizona median
- Medicare services
- 709vs 89421% below
- Medicare patients
- 262vs 35025% below
- Part D claims
- 681vs 58716% above
Medians across 62 medical oncologists in Arizona with Dmand AI profiles that report each measure.
Dr. Mahmoud's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mahmoud?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mahmoud and other medical oncologists in Arizona.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Fade A. Mahmoud treated 262 Medicare patients in 2024, average age 75
CMS counts 262 Medicare patients who saw Dr. Mahmoud in 2024. The largest group is 75 to 84, with 115 patients. 74% of them have high blood pressure, and 73% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mahmoud's median patient age at 68, with 41% women.
Dr. Mahmoud's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Mahmoud's Medicare patients by sex, 2024
- Women8934%
- Men17366%
Chronic conditions among Dr. Mahmoud's Medicare patients, 2024
- High blood pressure74%
- High cholesterol73%
- Arthritis45%
- Ischemic heart disease36%
- Cancer32%
- Chronic kidney disease26%
- Diabetes24%
- Atrial fibrillation21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mahmoud's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women41%
- Men58%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Fade A. Mahmoud wrote 875 Medicare Part D claims in 2024
In 2024, Dr. Mahmoud wrote 875 Medicare Part D claims for 165 patients. 71% of them were for generic drugs. CMS names the drug for 681 of them, across 23 drugs with 11 or more claims each, at $2,816,665 in total drug cost. In 2023, CMS named 683 claims across 28 drugs.
Dr. Mahmoud's Part D claims by kind of drug, 2024
- Generic619 claims71%
- Brand-name and other256 claims29%
Dr. Mahmoud's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Mahmoud's Part D claims, 2024
- Opioids7%60 of 875 claims
- Antibiotics2%18 of 875 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6832024: 681No change
Drugs named by CMS: 23 in 2024, 28 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Fade A. Mahmoud scored 78 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Mahmoud for performance year 2024, reported as part of a group. Dr. Mahmoud accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mahmoud as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Mahmoud's MIPS scores, performance year 2024
- 78of 100Final score
- 62.2of 100Quality
- 99of 100Promoting Interoperability
- 40of 100Improvement Activities
- 61of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Fade A. Mahmoud has 50 publications on record
Dmand AI links 50 papers to Dr. Mahmoud, published from 2002 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Melanoma, Antineoplastic Agents and Skin Neoplasms. Dr. Mahmoud has published most often in Perm J. Dr. Mahmoud's most frequent co-authors are Issam Makhoul, MD, Konstantinos Arnaoutakis, MD and Krishna Prasad Joshi, MD.
Dr. Mahmoud's papers by year, 2009 to 2025
Topics Dr. Mahmoud writes about most
- Melanoma
- Antineoplastic Agents
- Skin Neoplasms
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Immunological
- Immunotherapy
- Palliative Care
- Antibodies, Monoclonal
Dr. Mahmoud's most frequent co-authors
- Issam Makhoul, MD8 shared papers
- Konstantinos Arnaoutakis, MD4 shared papers
- Krishna Prasad Joshi, MD3 shared papers
Recent publications by Dr. Mahmoud
Curr Oncol Rep
See who Dr. Mahmoud researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mahmoud works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Fade A. Mahmoud has worked on 5 clinical trials
Dmand AI links Dr. Mahmoud to 5 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Diabetes Mellitus, Insulin-Dependent, 12. National Cancer Institute (NCI) sponsors the most, 2.
Clinical trials with Dr. Mahmoud by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Mahmoud's trials
- Melanoma
- Nevi and Melanomas
- Diabetes Mellitus, Insulin-Dependent, 12
- Squamous Cell Carcinoma of Head and Neck
- Carcinoma, Squamous Cell
Investigators on the most trials with Dr. Mahmoud
- Issam Makhoul, MD3 shared trials
- Inderjit Mehmi, MD3 shared trials
- Natale Tate Sheehan, MD3 shared trials
Recent clinical trials with Dr. Mahmoud
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) (opens in a new tab)
A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (opens in a new tab)
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery (opens in a new tab)
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Fade A. Mahmoud received $14,540 in industry payments from 2017 to 2025
CMS Open Payments shows 40 general payments to Dr. Mahmoud from 12 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 85% of the total. Bristol-Myers Squibb Company paid the most, $7,486.
General payments to Dr. Mahmoud by program year, 2017 to 2025
General payments to Dr. Mahmoud by kind, 2017 to 2025
- Consulting fees$12,41085%
- Speaker and faculty fees$1,2609%
- Food and beverage$6815%
- Travel and lodging$1271%
- Education$620%
Companies that paid Dr. Mahmoud the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Fade A. Mahmoud graduated from University of Tichreen Faculty of Medicine
Dr. Mahmoud graduated from University of Tichreen Faculty of Medicine in 1996.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Fade A. Mahmoud accepts plans from 20 insurance carriers
Dr. Mahmoud is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Blue Cross Blue Shield of Michigan
- Cigna
- United Healthcare
- HCSC
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- +12 more carriersWith a free account
Plan types Dr. Mahmoud accepts, by number of carriers
- PPO12
- Medicare11
- HMO8
- POS6
- EPO4
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Fade A. Mahmoud's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Fade A. Mahmoud
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Fade A. Mahmoud's NPI number?
Dr. Fade A. Mahmoud's NPI number is 1568420966. It was assigned on May 3, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Fade A. Mahmoud?
Dr. Fade A. Mahmoud is a medical oncologist in Gilbert, Arizona. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Fade A. Mahmoud practice?
Dr. Mahmoud practices at 1900 North Higley Road, Gilbert, AZ 85234. Dr. Mahmoud's primary practice is Banner Gateway Medical Center in Gilbert, Arizona, part of Banner Health. Dmand AI also links Dr. Mahmoud to 1 hospital and 1 group practice or clinic.
What is Dr. Fade A. Mahmoud's office phone number?
The practice phone on file for Dr. Mahmoud is (480) 543-2000.
What is Dr. Fade A. Mahmoud's medical license number?
Dr. Mahmoud holds Arizona license 54812, one of the licenses on file in 5 states.
Which states has Dr. Fade A. Mahmoud been licensed in?
Dmand AI has state licenses on file for Dr. Mahmoud in Arizona (2017 to 2027), California (since 2010), Colorado (2021 to 2027), Arkansas (2012 to 2018) and Massachusetts (2006 to 2017).
Which hospitals is Dr. Fade A. Mahmoud affiliated with?
Dr. Mahmoud practices at Banner Gateway Medical Center in Gilbert, Arizona. Dr. Mahmoud is also affiliated with Banner Thunderbird Medical Center. Dmand AI links Dr. Mahmoud to 1 more hospital.
What medical group is Dr. Fade A. Mahmoud part of?
Dr. Mahmoud is linked to Banner Cancer Center Specialists LLC.
Does Dr. Fade A. Mahmoud accept Medicare?
Yes. CMS data shows Dr. Mahmoud billed Medicare for 709 services in 2024, and Dr. Mahmoud accepts Medicare assignment.
Does Dr. Fade A. Mahmoud offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mahmoud as offering telehealth services.
Show 11 more questionsShow fewer questions
What is Dr. Fade A. Mahmoud's MIPS score?
Dr. Mahmoud's MIPS final score for performance year 2024 is 78 out of 100, reported as part of a group.
How many Medicare patients does Dr. Fade A. Mahmoud see?
CMS counts 262 Medicare patients who saw Dr. Mahmoud in 2024, with an average age of 75.
Is Dr. Fade A. Mahmoud board certified?
Yes. Dr. Mahmoud is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Fade A. Mahmoud bill to Medicare?
In 2024, Dr. Mahmoud's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, established patient (99215).
Where did Dr. Fade A. Mahmoud go to medical school?
Dr. Mahmoud graduated from University of Tichreen Faculty of Medicine in 1996.
What drugs does Dr. Fade A. Mahmoud prescribe most?
In 2024 Medicare Part D data, Dr. Mahmoud's most prescribed drugs by claims were Prednisone, Levothyroxine Sodium and Oxycodone HCl.
Has Dr. Fade A. Mahmoud received payments from drug or device companies?
CMS Open Payments shows $14,540 in general payments to Dr. Mahmoud from 12 companies from 2017 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Fade A. Mahmoud been practicing?
Dr. Mahmoud graduated from medical school in 1996, 30 years ago.
Does Dr. Fade A. Mahmoud do research?
Dmand AI links 50 publications to Dr. Mahmoud, published from 2002 to 2025. Dr. Mahmoud has worked on 5 clinical trials.
Who does Dr. Fade A. Mahmoud publish with?
Dr. Mahmoud's most frequent co-authors are Issam Makhoul, MD (8 shared papers), Konstantinos Arnaoutakis, MD (4 shared papers) and Krishna Prasad Joshi, MD (3 shared papers).
What insurance does Dr. Fade A. Mahmoud accept?
Dr. Mahmoud is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Arizona by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card